Ally Bridge Group

Ally Bridge Group

Ally Bridge Group

Pulse 2.0

Shockwave Medical (SWAV) Stock: Why The Price Climbed 10.78% After Hours Today

Pulse 2.0

Rapid Micro Biosystems (RPID) Stock: Why The Price Surged Today

Pulse 2.0

Shockwave Medical (SWAV) Stock: $200 Price Target And Buy Rating

GeekWire

Chinook Therapeutics helps form China-based biotech venture to treat kidney disease

$215,000,000 Venture capital (Series B)
MedCity News

CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies

$140,000,000 Venture capital
MedCity News

Shoreline Biosciences secures $140M for off-the-shelf NK cell therapies for cancer

$135,000,000 Venture capital (Series E)
MedCity News

Cerner joins $135M funding round for Elligo Health Research 

$265,000,000 Venture capital (Series B)
GeekWire

Sonoma Biotherapeutics raises $265M to advance therapies for autoimmune, inflammatory diseases

$106,000,000 Post-IPO equity
FinSMEs

Chinook Therapeutics Raises $106M in Funding

GeekWire

Chinook Therapeutics raises $106M as it prepares to merge with Aduro Biotech

GeekWire

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

Xconomy

Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech

$120,000,000 Venture capital
FinSMEs , DealStreetAsia

Rapid Micro Biosystems Raises $120M in Funding

$390,000,000 Venture capital (Series D)
FinSMEs

Grail Raises $390M in Series D Financing

$66,000,000 Venture capital (Series H)
FinSMEs

Pulmonx Raises $66M in Financing

$40,000,000 Venture capital (Series A)
Pulse 2.0

T Cell Therapy Company Sonoma Biotherapeutics Raises $40 Million

$65,000,000 Undisclosed
DealStreetAsia

HK’s Ally Bridge Group leads $65m financing for US-based Pulmonx

MedCity News

Report: Diagnostics unicorn Grail considering an IPO in the US, possibly next year

$421,000,000 IPO
AVCJ

Innovent Biologics gains on debut after $421m IPO

PE HUB

China's Innovent prices HK IPO near top end, raises $421 million, say sources: Reuters